🇺🇸 FDA
Company

Karyopharm

Karyopharm Therapeutics

KPTI pharma USA

Quick answer

Karyopharm is a pharma company (KPTI) headquartered in NEWTON, MA, USA with 24 tracked pipeline programs.

Pipeline (24)

project

Selinexor

Dedifferentiated Liposarcoma

Phase 3 · small_molecule · completed

1 trials project

Selinexor

Endometrial Cancer

Phase 3 · small_molecule · active

2 trials project

Selinexor

Myelofibrosis

Phase 3 · small_molecule · active

2 trials project

Selinexor

Multiple Myeloma

Phase 3 · small_molecule · active

12 trials project

Selinexor (combination therapy)

Relapsed/Refractory Diffuse Large B-cell Lymphoma

Phase 3 · small_molecule · active

1 trials project

Abemaciclib, dexamethasone, ixazomib, pomalidomide

Relapsed Refractory Multiple Myeloma

Phase 2 · small_molecule · completed

1 trials project

Cyclophosphamide

Myeloma Multiple

Phase 2 · small_molecule · terminated

1 trials project

Decitabine

Ovarian Cancer

Phase 2 · small_molecule · active

1 trials project

Docetaxel

Recurrent Squamous Cell Lung Carcinoma

Phase 2 · small_molecule · terminated

1 trials project

Elotuzumab, Selinexor, and Dexamethasone (ESd)

Relapsed Multiple Myeloma

Phase 2 · small_molecule · terminated

1 trials project

Ibrutinib

Lymphoma

Phase 2 · small_molecule · active

1 trials project

KPT-8602

Relapsed/Refractory Multiple Myeloma (RRMM)

Phase 2 · small_molecule · completed

1 trials project

Open Label Selinexor

Thymoma

Phase 2 · small_molecule · terminated

1 trials project

Pacritinib

Myelofibrosis

Phase 2 · small_molecule · active

1 trials project

Pembrolizumab

Advanced Urothelial Carcinoma

Phase 2 · mab · terminated

1 trials project

Selinexor

Acute Myeloid Leukemia (Relapsed/Refractory)

Phase 2 · small_molecule · completed

1 trials project

Selinexor

Coronavirus Infection

Phase 2 · small_molecule · completed

2 trials project

Selinexor

Diabetic Foot Ulcers

Phase 2 · small_molecule · terminated

1 trials project

Selinexor

Diffuse Large B-cell Lymphoma

Phase 2 · small_molecule · active

1 trials project

Selinexor

Breast Cancer

Phase 2 · small_molecule · completed

1 trials project

Selinexor

Carcinoma, Neuroendocrine

Phase 2 · small_molecule · completed

1 trials project

Selinexor

Glioblastoma

Phase 2 · small_molecule · terminated

1 trials project

Selinexor

Acute Myeloid Leukemia

Phase 2 · small_molecule · completed

1 trials project

Selinexor

Acute Myeloid Leukemia (AML)

Phase 2 · small_molecule · completed

3 trials

Drugs (1)

drug

selinexor

XPOVIO

Patents (8)

patent

US 12371420

Polymorphs of Selinexor

Expires Mon Jul 24 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 12331040

Substituted benzofuranyl and benzoxazolyl compounds and uses thereof

Expires Mon Jun 12 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 12318386

Combination of XPO1 inhibitors and second agents for the treatment of prostate c

Expires Mon May 29 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 12291508

Hydrazide containing nuclear transport modulators and uses thereof

Expires Mon May 01 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 11945794

Nuclear transport modulators and uses thereof

Expires Mon Mar 28 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 11807629

Polymorphs of Selinexor

Expires Mon Nov 02 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 11787771

Hydrazide containing nuclear transport modulators and uses thereof

Expires Mon Oct 12 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 11753401

Polymorphs of Selinexor

Expires Mon Sep 07 2043 00:00:00 GMT+0000 (Coordinated Universal Time)